EPCAM and neoplasm: Using whole-exome sequencing we were unable to detect tumor variants in the bulk lymph nodes, however a key enrichment step for the EPCAM+CD44+CD49f+ subpopulation through fluorescence activated cell sorting provided the sensitivity needed to identify the presence of micrometastases in the lymph nodes.